Latest News

Key Insights Significant insider control over FSA Group implies vested interests in company growth The top 4...

ZEAL Network (XTRA:TIMA) reported annual earnings growth of 6.68% and revenue growth of 8.3%, outperforming the German market’s 6.1% revenue expansion forecast. Net profit margins stand at 20.8%, down from 30.7% a year earlier. This highlights recent pressures despite a five-year stretch of 42.2% annualized earnings growth and persistent high-quality results. Investors are weighing this mix of sustained top-line progress, sliding margins, and flagged concerns around dividend sustainability as...

Wondering whether Dream Finders Homes is a hidden bargain, an overpriced risk, or something in between? You are not alone. Today's market moves have many investors asking the same question. The stock has taken a wild ride recently, dropping 10.6% in the last week and down 24.6% over the past month, with year-to-date returns at -15.7%. Looking further back, shares are still up an impressive 92.9% over the last three years, even after a tough 12 months marked by a -38.9% decline. Much of this...

Wondering if MarketAxess Holdings is a bargain or overpriced these days? You are not alone, especially as investors rethink what “fair value” really means for fintech leaders right now. The stock has faced a rough patch, dropping 4.1% over the past month and a steep 28.5% so far this year. This might signal new risks or hidden opportunities worth exploring. Recent news coverage has highlighted renewed competition in electronic bond trading and regulatory shifts in the U.S. fixed income...

Ever looked at Bausch + Lomb stock and wondered if it might finally be offering value worth grabbing? You are not alone, especially as healthcare stocks draw more attention in shifting markets. The stock recently gained 1.7% over the past week and is up 5.6% in the last 30 days. However, it remains down 12.6% year-to-date and nearly 21% over the past year. Analysts have been buzzing as Bausch + Lomb captured attention in the financial press with updates on product launches and regulatory...

Betmakers Technology Group Ltd ( ASX:BET ) shares have had a horrible month, losing 26% after a relatively good period...

Curious about whether Reynolds Consumer Products could be the value pick you've been searching for, or if there are red flags hiding beneath the surface? The stock price has seen only minor shifts lately, slipping 0.8% over the past week and remaining almost flat over the last month. However, it is still down 7.7% so far this year. Recent headlines show that industry trends and shifting consumer habits are in focus, with analysts watching closely as grocers adjust shelf space for household...

Investors Title (ITIC) reported a net profit margin of 13.2%, topping last year’s 11.8%, with annual earnings growth coming in at 26.2%. This turnaround stands out after a five-year period in which earnings had declined by an average of 16.1% per year, even as the company’s earnings remain classified as high quality. Investors now face a balance between the sharp recent recovery in margins and the stock’s relatively high valuation compared to both peers and the wider US insurance sector. See...

McDonald’s (MCD) reported earnings growth of 1% in the most recent year, falling short of its strong 9.9% per year average over the past five years. Net profit margins stand at 32.2%, slightly down from 32.3% a year ago, while revenue is forecast to grow at 5.2% per year, slower than the broader US market's 10.4% pace. Looking forward, the company’s earnings are projected to rise at 6.8% per year, lagging behind the US market average of 15.8%. Investors may weigh these results against...

Wondering whether SiteOne Landscape Supply stock is truly a bargain, overpriced, or somewhere in between? You are definitely not alone in trying to make sense of what the latest numbers are really saying about its value. The stock price has slipped recently, with a 6.0% drop over the past week and a 17.5% decline in the last year. This hints at shifting investor sentiment and potentially new risks or opportunities. This downward move has closely followed reports of changing market dynamics...

Wondering if Avino Silver & Gold Mines is still a value play after such a wild ride? You are not alone, and there is plenty to unpack if you are weighing whether to buy, sell, or hold. The stock surged an incredible 322.3% year-to-date and is up 255.8% over the past year, but has pulled back recently with a 21.9% drop in the past month. Much of the action has been sparked by renewed excitement in precious metals and some high-profile exploration updates from Avino's projects, fueling both...

EBOS Group (NZSE:EBO) just opened its new Symbion pharmacy wholesale distribution centre in Kemps Creek, Sydney. This marks a big step forward in the company's four-year, $360 million facility renewal program. This new centre focuses on automation, efficiency, and future growth potential. See our latest analysis for EBOS Group. After a tough year that saw EBOS Group log a one-year total shareholder return of -18.7% and a year-to-date share price decline of 24.2%, momentum has softened even as...

EDU Holdings Limited ( ASX:EDU ) shares have retraced a considerable 28% in the last month, reversing a fair amount of...

Redox (ASX:RDX) has had a great run on the share market with its stock up by a significant 17% over the last three...

Tian An Australia Limited ( ASX:TIA ) shares have continued their recent momentum with a 32% gain in the last month...

There wouldn't be many who think Nuchev Limited's ( ASX:NUC ) price-to-sales (or "P/S") ratio of 1.1x is worth a...

Ever wondered if Innoviva might be hiding some real value, or if it is just another biotech stock flying under the radar? You are not alone. Let’s dive in and see what sets it apart right now. Innoviva's stock has climbed 3.8% in the past week and 4.8% year-to-date, though it is still down 8.5% over the last year. This shows both recent momentum and a hint of volatility. Investors took notice as Innoviva finalized its acquisition of a smaller biotech firm, adding promising drug candidates to...

AMG Critical Materials (ENXTAM:AMG) posted a strong set of headline numbers, with earnings forecast to grow 39.9% per year, well ahead of the Dutch market’s 11.2% growth rate. Revenue, meanwhile, is expected to rise 4.7% annually, trailing the broader market’s 7.8%. The company has recently returned to profitability and has grown earnings by 7.4% per year over the past five years.

Select Water Solutions (WTTR) has posted five years of profitable growth, with annual earnings increasing an impressive 75.6% during that stretch. However, the company’s latest results show a net profit margin of 2.3%, down from 3.9% last year. Revenue is forecast to grow at just 1.3% per year, in comparison to the US market’s 10.5%. Shares currently trade at $11.48, well below the discounted cash flow fair value estimate of $19.55. The price-to-earnings ratio sits at a premium 36.2x versus...

Patria Investments (PAX) reported a net profit margin of 21.2%, down from last year’s 26%, and earnings growth of 3.2% in the latest year, despite a flat longer-term track record. The consensus expects profit to expand by 30.5% annually over the next three years, while revenue is forecast to grow at 13.5% per year, outpacing the US market average of 10.5%. Shares currently trade above estimated fair value at $15.2 versus $10.9, and a hefty Price-to-Earnings ratio of 28.8x points to a lot of...

Organon & Co. ( NYSE:OGN ) shareholders won't be pleased to see that the share price has had a very rough month...

First Majestic Silver (TSX:AG) has swung into profitability, reversing a period of losses and signaling a clear shift in its earnings profile. Over the past year, the company improved its net profit margin and is now projected to grow earnings at 32.3% per year, outpacing both its historical performance and industry expectations. Revenue is forecast to increase at 16.3% annually, which stands above the broader Canadian market average. With high-quality earnings and a trading price below...

Ever wondered if Atlas Energy Solutions stock is a bargain or just another name in the headlines? If you are curious about value—not just price—this could be the stock to watch. This year, shares have dropped a steep 51.1%, with a 7-day slide of 6.9% and a 30-day loss of 5.5%. These movements hint at both changing risk perceptions and possible opportunity for bold investors. Market chatter has focused on shifting industry dynamics, with headlines highlighting Atlas Energy Solutions’...

ASKA Pharmaceutical Holdings (TSE:4886) posted a net profit margin of 7.1% for the latest period, down from 9.4% a year earlier, while also recording a one-off gain of ¥1.2 billion ahead of September 2025. Over the last five years, earnings grew at an average rate of 18% annually. However, the most recent year saw a decline, and both earnings and revenue are now forecast to rise at a more modest 2.9% per year, lagging the broader Japanese market’s growth expectations. With a current...